|
JP2020070287A
|
|
Orally disintegrable tablets and methods of making the same
|
|
JP2019210276A
|
|
Tablet and method for producing the same
|
|
JP2019210218A
|
|
Tablet and method for producing the same
|
|
JP2019085338A
|
|
Lyophilized pharmaceutical composition containing bortezomib
|
|
JP2019059702A
|
|
Intraoral disintegrable tablet
|
|
JP2019038758A
|
|
Pharmaceutical composition containing palonosetron or pharmaceutically acceptable salt thereof
|
|
JP2019001730A
|
|
Sable oral pharmaceutical composition
|
|
JP2019001731A
|
|
Oral pharmaceutical composition having excellent hardness and disintegration property
|
|
JP2018150287A
|
|
Oral pharmaceutical composition with discomfort taste masked
|
|
JP2018024621A
|
|
Pharmaceutical composition which comprises palonosetron or a pharmaceutically acceptable salt thereof
|
|
JP2017171645A
|
|
Methods of producing and stabilizing aqueous pharmaceutical composition containing oxaliplatin
|
|
JP2017171602A
|
|
Methods of producing and stabilizing aqueous pharmaceutical composition containing oxaliplatin
|
|
JP2017149432A
|
|
Packing box
|
